These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2911833)
41. Variable platelet response to aspirin in patients with ischemic stroke. Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543 [TBL] [Abstract][Full Text] [Related]
42. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549 [TBL] [Abstract][Full Text] [Related]
43. The use of antithrombotic drugs in older people. Tufano A; Cerbone AM; Di Minno G Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611 [TBL] [Abstract][Full Text] [Related]
44. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke]. Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038 [TBL] [Abstract][Full Text] [Related]
45. Treatment of acute ischemic stroke: where are we? Mohr JP; Hartmann A Neurologia; 1999 Jan; 14(1):6-10. PubMed ID: 10079685 [No Abstract] [Full Text] [Related]
46. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684 [TBL] [Abstract][Full Text] [Related]
50. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Butterworth RJ; Cluckie A; Jackson SH; Buxton-Thomas M; Bath PM Cerebrovasc Dis; 1998; 8(3):158-65. PubMed ID: 9619699 [TBL] [Abstract][Full Text] [Related]
51. XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy. Genton E; Barnett HJ; Fields WS; Gent M; Hoak JC Stroke; 1977; 8(1):150-75. PubMed ID: 835152 [TBL] [Abstract][Full Text] [Related]
52. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521 [TBL] [Abstract][Full Text] [Related]
53. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease. Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510 [TBL] [Abstract][Full Text] [Related]
54. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Chaturvedi S; Ansell J; Recht L Stroke; 1994 Jun; 25(6):1215-8. PubMed ID: 8202983 [TBL] [Abstract][Full Text] [Related]
55. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054 [TBL] [Abstract][Full Text] [Related]
57. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke. Zhao L; Fletcher S; Weaver C; Leonardi-Bee J; May J; Fox S; Willmot M; Heptinstal S; Bath P Thromb Haemost; 2005 Mar; 93(3):527-34. PubMed ID: 15735805 [TBL] [Abstract][Full Text] [Related]